Holen Sie sich die Stockscreener-App
9.48
0.85%
0.08
Vorhandelsmarkt:
9.50
0.02
+0.21%
Schlusskurs vom Vortag:
$9.40
Offen:
$9.51
24-Stunden-Volumen:
238.61K
Relative Volume:
0.43
Marktkapitalisierung:
$328.96M
Einnahmen:
$2.07M
Nettoeinkommen (Verlust:
$-47.68M
KGV:
-3.3617
EPS:
-2.82
Netto-Cashflow:
$-31.31M
1W Leistung:
-0.21%
1M Leistung:
-8.58%
6M Leistung:
-10.99%
1J Leistung:
-42.09%
1-Tages-Spanne:
$9.41
$9.6507
1-Wochen-Bereich:
$8.94
$9.6507
52-Wochen-Spanne:
$8.12
$18.23
Delcath Systems Inc Stock (DCTH) Company Profile
Firmenname
Delcath Systems Inc
Sektor
Branche
Telefon
(518) 743-8892
Adresse
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Compare DCTH vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
9.48 | 326.18M | 2.07M | -47.68M | -31.31M | -2.82 |
|
ABT
Abbott Laboratories
|
113.29 | 195.21B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
377.32 | 141.28B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
98.49 | 123.60B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
76.28 | 113.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.98 | 45.52B | 6.07B | 1.06B | 799.60M | 1.8527 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-28 | Eingeleitet | Craig Hallum | Buy |
| 2024-05-14 | Eingeleitet | Stephens | Overweight |
| 2022-07-26 | Fortgesetzt | Canaccord Genuity | Buy |
| 2021-12-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-03-09 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-01-05 | Eingeleitet | BTIG Research | Buy |
| 2020-06-01 | Eingeleitet | Laidlaw | Buy |
Alle ansehen
Delcath Systems Inc Aktie (DCTH) Neueste Nachrichten
Clear Street raises Delcath Systems, Inc. (DCTH) target to $29, maintains buy rating - MSN
Technical Reactions to DCTH Trends in Macro Strategies - Stock Traders Daily
Is Delcath Systems Inc. stock a safe investment in uncertain marketsIPO Watch & AI Enhanced Market Trend Forecasts - mfd.ru
Does The Market Have A Low Tolerance For Delcath Systems, Inc.'s (NASDAQ:DCTH) Mixed Fundamentals? - Yahoo Finance
Delcath Systems, Inc. (DCTH) Stock Analysis: Exploring a Compelling 144.88% Upside Potential - DirectorsTalk Interviews
Delcath Systems to Host Fourth Quarter and Full Year 2025 Earnings Call - BioSpace
Is Delcath Systems Inc. a strong candidate for buy and hold2025 Support & Resistance & Daily Stock Trend Reports - mfd.ru
Will Delcath Systems Inc. stock recover faster than peers2025 Biggest Moves & AI Driven Price Forecasts - mfd.ru
Clear Street Raises Delcath Systems, Inc. (DCTH) Target to $29, Maintains Buy Rating - Insider Monkey
10 Best Long Term Healthcare Stocks to Buy - Insider Monkey
Fund Flows: Is Delcath Systems Inc subject to activist investor interestWeekly Investment Report & Risk Controlled Swing Alerts - baoquankhu1.vn
Trading the Move, Not the Narrative: (DCTH) Edition - Stock Traders Daily
Canaccord Genuity Sticks to Their Buy Rating for Delcath Systems (DCTH) - The Globe and Mail
The Robot Revolution Is Here: Stocks to Consider from Tesla, Hyundai, and Others. - Intellectia AI
Delcath Systems, Inc. (NASDAQ:DCTH) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Delcath Systems Faces Valuation Shift Amidst Mixed Financial Indicators and Growth Trends - Markets Mojo
Aug Gainers: Can Delcath Systems Inc continue delivering strong returns2025 Year in Review & Capital Efficient Trade Techniques - baoquankhu1.vn
Can Delcath Systems Inc. continue delivering strong returnsJuly 2025 Closing Moves & Safe Entry Momentum Tips - mfd.ru
Liver cancer-focused Delcath joins BTIG MedTech, digital health conference - Stock Titan
Delcath Systems to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Yahoo Finance
(DCTH) Volatility Zones as Tactical Triggers - Stock Traders Daily
Analysis Recap: Is CYCCP forming a double bottomMarket Growth Report & Real-Time Market Sentiment Reports - baoquankhu1.vn
Retail Surge: Can Delcath Systems Inc continue delivering strong returnsQuarterly Portfolio Review & Consistent Return Investment Signals - baoquankhu1.vn
Returns On Capital Are Showing Encouraging Signs At Delcath Systems (NASDAQ:DCTH) - Yahoo Finance
Delcath Systems, Inc. (DCTH) Stock Analysis: A 103% Upside Potential In Medical Devices - DirectorsTalk Interviews
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)January 21, 2026 - BioSpace
Delcath Systems, Inc. announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Is Delcath Systems Inc backed by strong institutional buyingLong Setup & Daily Growth Stock Investment Tips - baoquankhu1.vn
UTSW first in Texas to offer novel treatment for rare eye cancer that spreads to the liver : Newsroom - UT Southwestern
Market Catalysts: Is ODYS forming a bullish divergenceEarnings Performance Report & Real-Time Buy Signal Notifications - baoquankhu1.vn
Price-Driven Insight from (DCTH) for Rule-Based Strategy - Stock Traders Daily
Delcath Systems expects FY revenue of $85.2 million - MSN
Delcath Systems: Stabilizing Fundamentals Justify A Rating Upgrade (NASDAQ:DCTH) - Seeking Alpha
Delcath Systems Reports Strong Preliminary 2025 Results - TipRanks
NY-based Delcath Systems expects Q4 2025 revenue to hit USD 20.7M - Medical Buyer
Delcath Systems, Inc. (NASDAQ:DCTH) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Delcath Systems, Inc. (NASDAQ:DCTH) Q2 2025 Earnings Call Transcript - MSN
EBITDA per share of Delcath Systems, Inc. – DUS:DV3R - TradingView — Track All Markets
Delcath reports $85.2 million in 2025 revenue, strong cash position By Investing.com - Investing.com Nigeria
Delcath Systems (NASDAQ:DCTH) Stock Rating Upgraded by Wall Street Zen - MarketBeat
DCTH FinancialsIncome Statement - Quiver Quantitative
DCTH: HC Wainwright Reiterates Buy Rating with $30 Price Target - GuruFocus
HC Wainwright Reaffirms Buy Rating for Delcath Systems (NASDAQ:DCTH) - MarketBeat
Delcath Systems, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year 2025 - MarketScreener
Delcath Systems (DCTH) Exceeds Revenue Expectations in Q4 and Fu - GuruFocus
Delcath Systems announces preliminary fourth quarter and full year 2025 financial results - marketscreener.com
Delcath reports $85.2 million in 2025 revenue, strong cash position - Investing.com
Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results - The AI Journal
Finanzdaten der Delcath Systems Inc-Aktie (DCTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):